Clinical Research Directory
Browse clinical research sites, groups, and studies.
Electroconvulsive Therapy (ECT) for Agitation in Dementia (AD)
Sponsor: Brent Forester
Summary
This study will explore the effect of ECT treatments plus usual care (ECT+UC) in reducing severe agitation in patients with moderate to severe dementia including Alzheimer's Disease, Vascular dementia, Frontotemporal dementia, and Dementia with Lewy Bodies. The study will also determine the tolerability/safety outcomes of ECT+UC.
Official title: Effect and Safety of Electroconvulsive Therapy Plus Usual Care for the Acute Management of Severe Agitation in Dementia
Key Details
Gender
All
Age Range
40 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2021-01-28
Completion Date
2025-05-31
Last Updated
2024-06-03
Healthy Volunteers
No
Conditions
Interventions
Electroconvulsive Therapy (ECT)
Stimulus method of delivery will be RUL electrode placement, and ultra-brief (UB) pulse width (0.25-0.37ms). At the first ECT session, seizure threshold (ST) will be determined by titration with the empirical dose titration method and subsequent treatments will be approximately 6 times the ST. Following other NIMH sponsored multicenter ECT studies (PRIDE, U01 MH055495), stimulus settings will be adjusted as needed during the ECT course based on seizure quality and treatment efficacy. Participants will be administered anesthesia.
Locations (5)
Emory Healthcare
Atlanta, Georgia, United States
McLean Hospital
Belmont, Massachusetts, United States
Pine Rest Christian Mental Health Services
Grand Rapids, Michigan, United States
Mayo Clinic
Rochester, Minnesota, United States
Northwell Health
Glen Oaks, New York, United States